You are here: Home: Meet The Professors Lung Vol. 1 Issue 1: Faculty disclosures

Faculty Affiliations

	Martin J Edelman, MD Professor of Medicine Director of Medical Thoracic Oncology University of Maryland Greenebaum Cancer Center Baltimore, Maryland		Alan B Sandler, MD Associate Professor of Medicine; Medical Director Thoracic Oncology; Director Vanderbilt-Ingram Cancer Center Affiliate Network Program, Vanderbilt University Medical Center Division of Hematology/Oncology Nashville, Tennessee
	Thomas J Lynch, MD Director, MGH Thoracic Oncology Center Deputy Chief Hematology Oncology Associate Professor of Medicine Massachusetts General Hospital Boston, Massachusetts		Mark A Socinski, MD Associate Professor of Medicine Multidisciplinary Thoracic Oncology Program Lineberger Comprehensive Cancer Center University of North Carolina Chapel Hill, North Carolina

Medical Oncologist Community Panel

Howard R Abel, MD Ft Lauderdale, Florida Samuel N Bobrow, MD New Haven, Connecticut Margaret A Deutsch, MD Raleigh, North Carolina Atif M Hussein, MD Hollywood, Florida

Noor M Merchant, MD Sebastian, Florida Kenneth K Ng, MD Rockville Centre, New York William G Reeves, MD Youngstown, Ohio Kert D Sabbath, MD Bethany, Connecticut

Mark A Taylor, MD Savannah, Georgia Paul L Weinstein, MD Stamford, Connecticut

CONTENT VALIDATION AND DISCLOSURES

Research To Practice is committed to providing its participants with high-quality, unbiased and state-of-the-art education. We assess potential conflicts of interest with faculty, planners and managers of CME activities. Real or apparent conflicts of interest are identified and resolved by a peer review content validation process. The content of each activity is reviewed by both a member of the scientific staff and an external independent reviewer for fair balance, scientific objectivity of studies referenced and patient care recommendations.
The scientific staff and consultants for Research To Practice are involved in the development and review of content for educational activities and report the following real or apparent conflicts of interest for themselves (or their spouses/partners) that have been resolved through a peer review process: Richard Kaderman, PhD, Neil Love, MD, Douglas Paley, Margaret Peng, Lilliam Sklaver Poltorack, PharmD, Ginelle Suarez, Chris Thomson, MD, MS, Erin Wall and Kathryn Ault Ziel, PhD — no real or apparent conflicts of interest to report; Sally Bogert, RNC, WHCNP — shareholder of Amgen Inc and Genentech Inc. Research To Practice receives education grants from Abraxis Oncology, Amgen Inc, AstraZeneca Pharmaceuticals LP, Bayer Pharmaceuticals Corporation/Onyx Pharmaceuticals Inc, Genentech Inc/OSI Pharmaceuticals Inc, Genomic Health Inc, Roche Laboratories Inc and Sanofi-Aventis, who have no influence on the content development of our educational activities.

In addition, the following faculty (and their spouses/partners) have reported real or apparent conflicts of interest that have been resolved through a peer review process:

Dr Edelman — Consulting Fees: Abraxis Oncology, Pharmacyclics, Sanofi-Aventis; Other: Abraxis Oncology, Sanofi-Aventis. Dr Lynch — Honoraria: AstraZeneca Pharmaceuticals LP, Eli Lilly and Company, Genentech Inc, OSI Pharmaceuticals, Sanofi-Aventis; Consulting Fees: Genentech Inc, Millennium Pharmaceuticals Inc, OSI Pharmaceuticals, Telik Inc; Advisor: Hana Biosciences Inc, ImClone Systems, Sanofi-Aventis. Dr Sandler — Consulting Fees: Genentech Inc, Sanofi-Aventis; Fees for Non-CME Services Received Directly from Commercial Interest or Their Agents: Genentech Inc; Contracted Research: Genentech Inc, Sanofi-Aventis. Dr Socinski — Fees for Non-CME Services Received Directly from Commercial Interest or Their Agents: Abraxis Oncology, Genentech Inc, Sanofi-Aventis; Contracted Research: Abraxis Oncology, Genentech Inc, Sanofi-Aventis.

This educational activity contains discussion of published and/or investigational uses of agents that are not indicated by the Food and Drug Administration. Research To Practice does not recommend the use of any agent outside of the labeled indications. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications and warnings. The opinions expressed are those of the presenters and are not to be construed as those of the publisher or grantor.